Gilead Sciences Inc. is expanding its manufacturing network to ramp up production of Covid-19 treatment remdesivir, and says it will be able to meet global demand in real time starting in October.
The company has struck a multiyear deal to have Pfizer Inc. manufacture the antiviral medication developed by Gilead.
The drug, which has been…